Skip to content

Visit us at www.anandandanand.com

Patents Rewind – An Anand and Anand Blog
  • PATENTS REWIND : AN ANAND AND ANAND BLOG
  • Uncategorized

    Amendment within the scope of the patent specification and claims as originally filed, allowed by the Delhi High Court

    Published by

    patents_rewind

    on

    July 7, 2022

    A recent appeal has been allowed by the Hon’ble High Court of Delhi and a refusal of the Patent office under Section 59, not allowing the revised claims filed by the appellant, has been reversed. The matter has been remanded back to the Patent office for reconsideration of the amended…

    Continue reading →: Amendment within the scope of the patent specification and claims as originally filed, allowed by the Delhi High Court
  • Uncategorized

    Applicant not to suffer, if no fault can be attributed to the Applicant

    Published by

    patents_rewind

    on

    June 15, 2022

    Two application that had been abandoned due to non-filing of response to the examination report have been restored by the Delhi High Court. The facts of the case are as follows:- Two writ petitions, W.P.(C)-IPD-5-2022 & W.P.(C)-IPD-6- 2022 had been filed by the Petitioner- the European Union is seeking setting…

    Continue reading →: Applicant not to suffer, if no fault can be attributed to the Applicant
  • Uncategorized

    Directions for IPR related suits issued by Delhi High Court

    Published by

    patents_rewind

    on

    June 8, 2022

    In an appeal challenging the order passed by the ld. ADJ-03, Patiala House Courts, New Delhi in the suit bearing TM 1/2022 titled Vishal Pipes Limited v. Bhavya Pipe Industry, a suit seeking permanent injunction against infringement of registered trademark and copyright as also other reliefs for usage of the…

    Continue reading →: Directions for IPR related suits issued by Delhi High Court
  • Indian Patent Office, Indian Patents Act, Infringement, Injunctions, Intellectual Property, IPR, Life Sciences

    Another injunction granted in favor of BOEHRING for the product Linagliptin

    Published by

    patents_rewind

    on

    June 8, 2022

    In an injunction application MSN Laboratories Private Limited, Eris pharmaceuticals, Emcure Pharmaceuticals, Optimus Pharma Private Limited have been injuncted/restrained from advertising, launching, making, using, offering for sale, selling, importing and/or exporting the medicinal product, Linagliptin in any form . The order of May 2022 disposes applications preferred under Order XXXIX,…

    Continue reading →: Another injunction granted in favor of BOEHRING for the product Linagliptin
  • Indian Patents Act, Infringement, Injunctions, Intellectual Property, IPR, Life Sciences, Pharmaceuticals

    Macleods Pharmaceuticals Limited injuncted from manufacturing Linagliptin in any from

    Published by

    patents_rewind

    on

    June 8, 2022

    The High Court Of Himachal Pradesh on 21st April 2022 granted a preliminary injunction in favor of Boehringer Ingelheim International GMBH & CO. KG (plaintiffs), and against Macleods Pharmaceuticals Limited (defendants). The order of April 2022 disposes an application preferred under Order XXXIX, Rules 1 and 2 of the Code…

    Continue reading →: Macleods Pharmaceuticals Limited injuncted from manufacturing Linagliptin in any from
  • Appeal, Indian Patent Office, Indian Patents Act, Information Communication Technology (ICT)

    Court directs Patent office to reconsider a patent application that was refused based on examination of unamended claims

    Published by

    patents_rewind

    on

    June 1, 2022

    An appeal under section 117A of the Patents Act, 1970 was filed challenging the order dated 12th June, 2020 passed by the Controller of Patents & Designs. Vide the said order, the Appellant’s (JITENDRA KOHLI) application No.3290/Del/2005 was rejected under Section 15 of the Act. Appellant filed a patent application…

    Continue reading →: Court directs Patent office to reconsider a patent application that was refused based on examination of unamended claims
  • Uncategorized

    Parliamentary Standing Committee Recommendations

    Published by

    patents_rewind

    on

    May 26, 2022

    The Department Related Parliamentary Standing Committee on Commerce presented its 169th report. The committee has made few recommendations to the Central Government, some of which are as follows: – Channelize efforts to encourage and empower AI innovators by enacting suitable legislations or modifying the existing laws on IPR in order…

    Continue reading →: Parliamentary Standing Committee Recommendations
  • Uncategorized

    Domestic patent filing surpasses international patent filing

    Published by

    patents_rewind

    on

    April 18, 2022

    As per a recent press release from the Ministry of Commerce and Industry, for the first time in 11 years, the number of domestic patent filing has surpassed the number of international patent filing in India during Jan-Mar 2022. The report also notes that the coordinated efforts by Department for…

    Continue reading →: Domestic patent filing surpasses international patent filing
  • Uncategorized

    Agriboard International LLC’s patent application remanded back to the patent office for reconsideration

    Published by

    patents_rewind

    on

    April 12, 2022

    An appeal under section 117A (2) of the Patents Act, 1970 was filed by Agriboard International LLC challenging the order passed by the Deputy Controller of Patents & Designs dated 16th June, 2021, vide which the Appellant’s patent application bearing no. 202014010848 was refused. The application was refused on the…

    Continue reading →: Agriboard International LLC’s patent application remanded back to the patent office for reconsideration
  • Uncategorized

    RESVERLOGIX CORP’S PATENT GRANTED AFTER APPEAL

    Published by

    patents_rewind

    on

    April 11, 2022

    The appellate board granted a patent to Resverlogix Corp. for an invention related toinflammatory agents for regulating interleukin-6 (IL-6) and/or vascular cell adhesion molecule (VCAM-1) after refusal by the patent office. The appellate authority considered the order of the controller to be against law and non-speaking. The order was based…

    Continue reading →: RESVERLOGIX CORP’S PATENT GRANTED AFTER APPEAL
Previous Page Next Page

Greetings

Welcome to Patents Rewind, Anand and Anand’s Patents and Designs blog that offers you an Indian perspective on issues surrounding patent and design eligibility and enforcement through latest case law and developments in the Indian patents and designs landscape.

Let’s connect

  • LinkedIn
  • Mail

Join us!

Stay updated with our posts.

Recent posts

  • Calcutta High Court Grants Interim Injunction in NOCIL’s 4-ADPA Process Patent and Trade Secret Dispute

  • Delhi High Court Grants Ex Parte Injunction Against Intas in Novartis’ Quia Timet Action Over Dabrafenib Patent

  • Delhi High Court Rejects Challenge to Territorial Jurisdiction in Patent Infringement Suit

  • Delhi High Court Grants Rs. 152 Crore Damages in Communication Components Antenna vs Rosenberger

  • No Mechanical Notices for Pre-Grant Opposition: Madras High Court Emphasises Application of Mind Under Rule 55(3)

  • Delhi High Court Holds Section 25(1) Pre-Grant Opposition Hearing Cannot Substitute Statutory Hearing Under Section 14

Patents Rewind – An Anand and Anand Blog

  • Mail
  • LinkedIn
  • PATENTS REWIND : AN ANAND AND ANAND BLOG

Blog at WordPress.com.

  • Subscribe Subscribed
    Patents Rewind - An Anand and Anand Blog
    Join 107 other subscribers

    Have a WordPress.com account? Log in now.

  • Patents Rewind - An Anand and Anand Blog
    View site in Reader
    Manage subscriptionsSign upLog in
    Report this content
    Collapse this bar

Notifications